Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer’s disease

OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) have increased cognitive performance in some clinical studies of Alzheimer’s disease (AD), but it is has been difficult to dissociate whether this is due to direct effects on cognition (neurochemical or disease-modifying) or a secondary effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Tiffany W, Pollock, Bruce G, Milgram, Norton W
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656299/
https://www.ncbi.nlm.nih.gov/pubmed/19300592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656299/
https://www.ncbi.nlm.nih.gov/pubmed/19300592

Ejemplares similares